FDA Approved: LAMOTRIGINE — Original Application (Yiling Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved Yiling Pharmaceutical's generic lamotrigine extended-release via Original Application (ANDA), enabling a generic lamotrigine ER product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine Extended-Release (Lamotrigine extended-release)

Snippet

ORIG AP for LAMOTRIGINE (LAMOTRIGINE EXTENDED-RELEASE)